These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35398383)

  • 1. Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, volume 165).
    Berger T; Noble DJ; Shelley LEA; Hopkins KI; McLaren DB; Burnet NG; Nailon WH
    Radiother Oncol; 2022 Jul; 172():151-152. PubMed ID: 35398383
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, Volume 165).
    Tuscano C; Al Sayyad S; Sceni G
    Radiother Oncol; 2022 Jul; 172():149-150. PubMed ID: 35413390
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor of radiotherapy and oncology regarding of the paper "Radiotherapy enhances uptake and efficacy of
    Chen J; Liu G
    Radiother Oncol; 2021 Aug; 161():260. PubMed ID: 34119588
    [No Abstract]   [Full Text] [Related]  

  • 4. Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Karam I; Voruganti IS; Poon I
    Radiother Oncol; 2022 May; 170():248-249. PubMed ID: 35278592
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Pergolizzi S; Ferini G; Parisi S
    Radiother Oncol; 2022 May; 170():247. PubMed ID: 35278593
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
    Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
    Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
    Beenakker JM; Rasch CRN
    Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor of radiotherapy and oncology regarding the article esposito et al: Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.
    Kos S
    Radiother Oncol; 2020 Dec; 153():319. PubMed ID: 32653600
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "Prospective Data Registration and Clinical Trials for Particle Therapy" by Langendijk et al.
    Laprie A; Bernier V; Carrie C;
    Radiother Oncol; 2019 Jan; 130():193. PubMed ID: 30360997
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to the letter to the editor by Macià i Garau et al. regarding the article "ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma" by Niyazi et al.
    Niyazi M; Bendszus M; Minniti G
    Radiother Oncol; 2024 Jan; 190():109965. PubMed ID: 37922992
    [No Abstract]   [Full Text] [Related]  

  • 11. 50 years of radiotherapy research: Evolution, trends and lessons for the future.
    Berger T; Noble DJ; Shelley LEA; Hopkins KI; McLaren DB; Burnet NG; Nailon WH
    Radiother Oncol; 2021 Dec; 165():75-86. PubMed ID: 34619236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of
    Dietrich A; Andreeff M; Koi L; Bergmann R; Schubert M; Schreiner L; Löck S; Sihver W; Freudenberg R; Hering S; Pietzsch HJ; Steinbach J; Kotzerke J; Baumann M; Krause M
    Radiother Oncol; 2021 Aug; 161():261-262. PubMed ID: 34119587
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor Regarding "Global Research Trends in Radiotherapy for Gliomas: A Systematic Bibliometric Analysis".
    Ho YS
    World Neurosurg; 2023 Feb; 170():251. PubMed ID: 36782411
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the editor regarding Mackillop et al., IJROBP 32:531-539; 1995.
    Rose CM
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):239-40. PubMed ID: 7642428
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology.
    Kavanagh BD
    Cancer J; 2016; 22(4):245-6. PubMed ID: 27441743
    [No Abstract]   [Full Text] [Related]  

  • 16. In reply to the letter to the editor: "In reply to Fiorino et al: The central role of the radiation oncologist in the multidisciplinary and multiprofessional model of modern radiation therapy".
    Fiorino C; Jeraj R; Clark CH; Garibaldi C; Georg D; Muren L; van Elmpt W; Bortfeld T; Jornet N
    Radiother Oncol; 2021 Feb; 155():e22-e23. PubMed ID: 33412208
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology at CERN: accelerating radiotherapy.
    Thornton J
    Lancet; 2023 Jan; 401(10371):92-93. PubMed ID: 36460030
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of symptom control and palliative care-focused original research articles in the International Journal of Radiation Oncology *Biology* Physics and the Radiotherapy and Oncology Journal, 2005-2014.
    Shi DD; DiGiovanni J; Skamene S; Noveroske Philbrick S; Wang Y; Barnes EA; Chow E; Sullivan A; Balboni TA
    Ann Palliat Med; 2018 Apr; 7(2):249-255. PubMed ID: 29764186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor concerning Valstar et al., [Radiother Oncol 2020 Sep 23;S0167-8140(20)30809-4. doi: 10.1016/j.radonc.2020.09.034].
    Bikker FJ; Vissink A
    Radiother Oncol; 2021 Jan; 154():318. PubMed ID: 33309998
    [No Abstract]   [Full Text] [Related]  

  • 20. The present and future of radiation oncology in Spain.
    Guedea F
    Clin Transl Oncol; 2011 Sep; 13(9):697-9. PubMed ID: 21865143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.